Literature DB >> 2212989

Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases.

M Wallin1, J Deinum, L Goobar, U H Danielson.   

Abstract

Aspartic proteinases from human immunodeficiency virus type 1 (HIV-1) and avian myeloblastosis virus (AMV) were found to interfere with microtubule assembly. Preincubation of the proteinases with purified brain microtubule proteins (tubulin and microtubule-associated proteins) at low ionic strength (pH 6.8), completely inhibited microtubule assembly. Analysis of microtubule proteins after incubation with proteinase showed no effect on tubulin but extensive cleavage of the microtubule-associated proteins 1 and 2 was observed. The digestion by the two proteinases differed. In the presence of HIV-1 proteinase, a fragment with an Mr of approximately 300, appeared, as well as at least three other new fragments, with Mr values of 188,000, 124,000 and 73,000. In the presence of AMV proteinase, the microtubule-associated proteins were extensively digested to many small fragments. The extending microtubule-associated proteins normally seen by electron microscopy on the microtubule surface disappeared after treatment with AMV proteinase. Our results show that retroviral proteinases are not restricted to cleavage of viral polyproteins in vitro. It is suggested that proteolysis of microtubular proteins by viral proteinases is an important step in viral pathogenicity and that it may be part of a mechanism causing degenerative effects in infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212989     DOI: 10.1099/0022-1317-71-9-1985

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.

Authors:  H G Kräusslich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Association of ebola virus matrix protein VP40 with microtubules.

Authors:  Gordon Ruthel; Gretchen L Demmin; George Kallstrom; Melodi P Javid; Shirin S Badie; Amy B Will; Timothy Nelle; Rowena Schokman; Tam L Nguyen; John H Carra; Sina Bavari; M Javad Aman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

Authors:  R L Shoeman; C Sachse; B Höner; E Mothes; M Kaufmann; P Traub
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

4.  Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Authors:  K Lindsten; T Uhlíková; J Konvalinka; M G Masucci; N P Dantuma
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.

Authors:  J Konvalinka; M A Litterst; R Welker; H Kottler; F Rippmann; A M Heuser; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown.

Authors:  Geert Van Minnebruggen; Herman W Favoreel; Liesbeth Jacobs; Hans J Nauwynck
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Poliovirus infection results in structural alteration of a microtubule-associated protein.

Authors:  M Joachims; D Etchison
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules.

Authors:  G Elliott; P O'Hare
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  HIV-2 Protease resistance defined in yeast cells.

Authors:  Najoua Ben M'Barek; Gilles Audoly; Didier Raoult; Pablo Gluschankof
Journal:  Retrovirology       Date:  2006-09-06       Impact factor: 4.602

10.  A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer.

Authors:  Kimberly Hu; Jean-Francois Clément; Levon Abrahamyan; Klaus Strebel; Michel Bouvier; Lawrence Kleiman; Andrew J Mouland
Journal:  J Virol Methods       Date:  2005-09       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.